News & Articles

This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility

Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing

Join us on Monday, September 21, to learn about assay development for high-throughput screening

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus

Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers

Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development

Watch this on-demand webinar to find out how Aerospray technology could elevate your lab’s performance

Rapid increase in production of VTM and saline will help boost virus testing

Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq

Join us to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors

Meet the researchers making waves in science and learn about the technologies innovating their research

Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva